GPRIN1 and gastric cancer: Zhou et al. (2021) demonstrated that miR-654-5p promotes gastric cancer progression by activating the NF-κB pathway via direct suppression of GPRIN1.[27] Our results genetically validate this earlier mechanistic finding, moving beyond correlation to establish a causal relationship.